Name |
(3S,5S,8S,9S,10S,13R,14S,17R)-17-[(1R)-1,5-dimethylhexyl]-3-(hydroxyamino)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-1-one oxime |
InChI |
InChI=1S/C27H48N2O2/c1-17(2)7-6-8-18(3)22-11-12-23-21-10-9-19-15-20(28-30)16-25(29-31)27(19,5)24(21)13-14-26(22,23)4/h17-24,28,30-31H,6-16H2,1-5H3/b29-25+/t18-,19+,20+,21+,22-,23+,24+,26-,27+/m1/s1 |
Synonyms |
(3S,5S,8S,9S,10S,13R,14S,17R)-3-(hydroxyamino)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-1-one oxime
(NE)-N-[(3S,5S,8S,9S,10S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-3-(oxidanylamino)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-1-ylidene]hydroxylamine
(NE)-N-[(3S,5S,8S,9S,10S,13R,14S,17R)-3-(hydroxyamino)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-1-ylidene]hydroxylamine |